181 related articles for article (PubMed ID: 37967346)
21. Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Dini FL; Gabutti A; Passino C; Fontanive P; Emdin M; De Tommasi SM
Int J Cardiol; 2010 Apr; 140(3):344-50. PubMed ID: 19128846
[TBL] [Abstract][Full Text] [Related]
22. Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation.
Giannopoulos G; Kossyvakis C; Angelidis C; Efremidis M; Panagopoulou V; Letsas K; Bouras G; Vassilikos VP; Goudevenos J; Tousoulis D; Lekakis J; Deftereos S
Heart Rhythm; 2015 Jul; 12(7):1470-5. PubMed ID: 25847478
[TBL] [Abstract][Full Text] [Related]
23. SERUM cardiac-specific biomarkers and atrial fibrillation in myotonic dystrophy type I.
Russo V; Rago A; Atripaldi L; Leonardi S; Papa AA; Politano L; Golino P; Potpara TS; Nigro G
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2914-2919. PubMed ID: 31579995
[TBL] [Abstract][Full Text] [Related]
24. N-terminal pro B-type natriuretic peptide in systematic screening for atrial fibrillation.
Svennberg E; Henriksson P; Engdahl J; Hijazi Z; Al-Khalili F; Friberg L; Frykman V
Heart; 2017 Aug; 103(16):1271-1277. PubMed ID: 28255099
[TBL] [Abstract][Full Text] [Related]
25. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study.
Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Frikke-Schmidt R; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
Circulation; 2023 Jun; 147(24):1788-1797. PubMed ID: 37061802
[TBL] [Abstract][Full Text] [Related]
26. Serum N-terminal pro-B-type natriuretic peptide as a predictor for future development of atrial fibrillation in a general population: the Hisayama Study.
Nagata T; Hata J; Sakata S; Oishi E; Honda T; Furuta Y; Ohara T; Yoshida D; Hirakawa Y; Shibata M; Ide T; Kitazono T; Tsutsui H; Ninomiya T
Int J Cardiol; 2020 Dec; 320():90-96. PubMed ID: 32592745
[TBL] [Abstract][Full Text] [Related]
27. Exploring the incremental utility of circulating biomarkers for robust risk prediction of incident atrial fibrillation in European cohorts using regressions and modern machine learning methods.
Toprak B; Brandt S; Brederecke J; Gianfagna F; Vishram-Nielsen JKK; Ojeda FM; Costanzo S; Börschel CS; Söderberg S; Katsoularis I; Camen S; Vartiainen E; Donati MB; Kontto J; Bobak M; Mathiesen EB; Linneberg A; Koenig W; Løchen ML; Di Castelnuovo A; Blankenberg S; de Gaetano G; Kuulasmaa K; Salomaa V; Iacoviello L; Niiranen T; Zeller T; Schnabel RB
Europace; 2023 Mar; 25(3):812-819. PubMed ID: 36610061
[TBL] [Abstract][Full Text] [Related]
28. N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex and ethnicity.
Patton KK; Heckbert SR; Alonso A; Bahrami H; Lima JA; Burke G; Kronmal RA
Heart; 2013 Dec; 99(24):1832-6. PubMed ID: 24131775
[TBL] [Abstract][Full Text] [Related]
29. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
[TBL] [Abstract][Full Text] [Related]
30. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
[TBL] [Abstract][Full Text] [Related]
31. Bone Morphogenetic Protein 10-A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation.
Hennings E; Blum S; Aeschbacher S; Coslovsky M; Knecht S; Eken C; Lischer M; Paladini RE; Krisai P; Reichlin T; Rodondi N; Beer JH; Ammann P; Conte G; De Perna ML; Kobza R; Blum MR; Bossard M; Kastner P; Ziegler A; Müller C; Bonati LH; Pfister O; Zuern CS; Conen D; Kühne M; Osswald S;
J Am Heart Assoc; 2023 Mar; 12(6):e028255. PubMed ID: 36926939
[TBL] [Abstract][Full Text] [Related]
32. NT -pro BNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure.
Whitman IR; Vittinghoff E; DeFilippi CR; Gottdiener JS; Alonso A; Psaty BM; Heckbert SR; Hoogeveen RC; Arking DE; Selvin E; Chen LY; Dewland TA; Marcus GM
J Am Heart Assoc; 2019 Apr; 8(7):e010868. PubMed ID: 30912456
[TBL] [Abstract][Full Text] [Related]
33. Elevated admission N-terminal pro-brain natriuretic peptide level predicts the development of atrial fibrillation in general surgical intensive care unit patients.
Chokengarmwong N; Yeh DD; Chang Y; Ortiz LA; Kaafarani HMA; Fagenholz P; King DR; DeMoya M; Butler K; Lee J; Velmahos G; Januzzi JL; Lee-Lewandrowski E; Lewandrowski K
J Trauma Acute Care Surg; 2017 Sep; 83(3):485-490. PubMed ID: 28463935
[TBL] [Abstract][Full Text] [Related]
34. Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
Tancin Lambert A; Ratajczak-Tretel B; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth HMO; Bjerkeli V; Eldøen G; Gulsvik AK; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Johansen H; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Naess H; Qazi R; Rezai MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; AEgidius KL; Pesonen M; de Melis M; Atar D; Aamodt AH;
Eur J Neurol; 2023 May; 30(5):1352-1363. PubMed ID: 36786305
[TBL] [Abstract][Full Text] [Related]
35. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
[TBL] [Abstract][Full Text] [Related]
36. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
[TBL] [Abstract][Full Text] [Related]
37. Relation of N-terminal pro-brain natriuretic peptide and new-onset atrial fibrillation in patients with acute coronary syndrome: a systematic review and meta-analysis.
Gao X; Zeng R; Liao P; Zhu H; Zhang M
Scand J Clin Lab Invest; 2016 Oct; 76(6):460-4. PubMed ID: 27347749
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-B-type natriuretic peptide improves the predictive value of CHA
Mu X; Qiu M; Li Y; Li Z; Qi B; Jing Z; Jing Q
Clin Cardiol; 2023 Jul; 46(7):810-817. PubMed ID: 37218400
[TBL] [Abstract][Full Text] [Related]
39. The use of N-terminal pro-brain natriuretic peptide as a predictor of atrial fibrillation after cardiac surgery.
Kallel S; Jarrya A; Triki Z; Abdenadher M; Frikha J; Karoui A
J Cardiovasc Surg (Torino); 2013 Jun; 54(3):403-11. PubMed ID: 23172377
[TBL] [Abstract][Full Text] [Related]
40. Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care.
Ghazal F; Theobald H; Rosenqvist M; Al-Khalili F
PLoS One; 2019; 14(2):e0212974. PubMed ID: 30807614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
